Monomeric C-reactive protein - A key molecule driving development of Alzheimer's disease associated with brain ischaemia?

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Slevin, M ^a,b,c   Matou, S ^a   Zeinolabediny, Y ^a   Corpas, R ⁱ   Weston, R ^a   Liu, D ^a   Boras, E ^a   Di Napoli, M ^d   Petcu, E ^c   Sarroca, S ⁱ   Popa Wagner, A ^e   Love, S ^f   Font, M A ^j   Potempa, L A ^g   Al Baradie, R ^h   Sanfeliu, C ⁱ   Revilla, S ⁱ   Badimon, L ^j   Krupinski, J ^k  

^a MANCHESTER METROPOLITAN UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^c GRIFFITH UNIVERSITY   (Australia)

^d SAN CAMILLO DE LELLIS HOSPITAL   (Italy)

^e UNIVERSITY MEDICINE GREIFSWALD   (Germany)

^f UNIVERSITY OF BRISTOL   (United Kingdom)

^g Acphazin Inc ^*  (United States)

^h MAJMAAH UNIVERSITY   (Saudi Arabia)

ⁱ INST D INVESTIGACIONS B   (Spain)

^j HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^k HOSPITAL MÚTUA DE TERRASSA   (Spain)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; C-REACTIVE PROTEIN RECEPTOR, HUMAN; IMMUNOGLOBULIN RECEPTOR;

ALZHEIMER DISEASE; ANIMAL; BRAIN ISCHEMIA; C57BL MOUSE; COMPLICATION; DISEASE COURSE; MALE; METABOLISM; MOUSE; NERVE CELL;

ALZHEIMER DISEASE; ANIMALS; BIOMARKERS; BRAIN ISCHEMIA; DISEASE PROGRESSION; MALE; MICE; MICE, INBRED C57BL; NEURONS; RECEPTORS, IMMUNOLOGIC;

EID: 84941013780     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep13281     Document Type: Article

References (55)

1. Desmond, D. W., Moroney, J. T., Sano, M., & Stern, Y. Incidence of dementia after ischemic stroke: results of a longitudinal study. Stroke, 33, 2254-2260. (2002
2. Iadecola, C., & Gorelick, P. B. Converging pathogenic mechanisms in vascular neurodegenerative dementia. Stroke. 34, 335-337 (2003
3. Kudo, T., et al. Are cerebrovascular factors involved in Alzheimer's disease? Neurobiol Aging. 21, 215-224 (2000
4. Marchesi, V. T. Alzheimer's dementia begins as a disease of small blood vessels, damaged by oxidative-induced inflammation and dysregulated amyloid metabolism: implications for early detection and therapy. FASEB J. 25, 5-13 (2011
5. Yasojima, K., Schwab, C., McGeer, E. G., & McGeer, P. L. Human neurons generate C-reactive protein and amyloid P: upregulation in Alzheimer's disease. Brain Res. 887, 80-89 (2000
6. Mancinella, A., et al. Is there a relationship between high C-reactive protein (CRP) levels and dementia? Arch Gerentol Geriatr. 49, 185-194 (2009
7. Slevin, M., & Krupinski, J. A role for monomeric C-reactive protein in regulation of angiogenesis, endothelial cell inflammation and thrombus formation in cardiovascular/cerebrovascular disease? Histol Histopathol. 24, 1473-1478. (2009
8. Slevin, M., et al. Modified C-reactive protein is expressed by stroke neovessels and is a potent activator of angiogenesis in vitro. Brain Pathol. 20, 151-165. (2010
9. Turu, M. M., et al. C-reactive protein exerts angiogenic effects on vascular endothelial cells and modulates associated signalling pathways and gene expression. BMC Cell Biol. 9, 47 (2008
10. Schwedler, S. B., et al. Native C-reactive protein increases whereas modified C-reactive protein reduces atherosclerosis in apolipoprotein E-knockout mice. Circulation. 112, 1016-1023 (2005
11. Strang, F., et al. Amyloid plaques dissociate pentameric to monomeric C-reactive protein: a novel pathomechanism driving cortical inflammation in Alzheimer's disease? Brain Pathol. 22, 337-346 (2012
12. Bulbarelli, A., et al. Aβ 42 production in brain capillary endothelial cells after oxygen and glucose deprivation. Mol. Cell Neurosci. 49, 415-422 (2012
13. Boras, E., et al. Monomeric C-reactive protein and Notch-3 co-operatively increase angiogenesis through PI3K signalling pathway. Cytokine. 69, 165-179 (2014
14. Sattar, A., et al. Application of angiogenic oligosaccharides of hyaluronan increases blood vessel numbers in rat skin. J Invest Dermatol. 103, 576-579 (1994
15. Bosutti, A., et al. Targeting p35/Cdk5 signalling via CIP-peptide promotes angiogenesis in hypoxia. PLoS One. 8, e75538 (2013
16. Mizoroki, T., et al. Aluminium induces tau aggregation in vitro but not in vivo. J. Alzheimers Dis. 11, 419-427 (2007
17. Revilla, S., et al. Physical exercise improves synaptic dysfunction and recovers the loss of survival factors in 3xTg-AD mouse brain. Neuropharmacology. 81, 55-63 (2014
18. Giménez-Llort, L., et al. Working memory deficits in transgenic rats overexpressing human adenosine A2A receptors in the brain. Neurobiol. Learn Mem. 87, 42-56 (2007
19. García-Mesa, Y., et al. Physical exercise protects against Alzheimer's disease in 3xTg-AD mice. J Alzheimers Dis. 24, 421-54 (2011
20. Mirra, S. S., et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology. 41, 479-486
21. Braak, H., Alafuzoff, I., Arzberger, T., Kretzschmar, H., & Del Tredici, K. Staging of Alzheimer disease-Associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol. 112, 389-404 (2006
22. Montine, T. J., et al. National Institute on Aging; Alzheimer's Association, National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach. Acta Neuropathol. 123, 1-11 (2012
23. Mitsios, N., et al. Expression of cyclin-dependent kinase 5 mRNA and protein in the human brain following acute ischemic stroke. Brain Pathol. 17, 11-23. (2007
24. Balczon, R., et al. Pseudomonas aeruginosa exotoxin Y-mediated tau hyperphosphorylation impairs microtubule assembly in pulmonary microvascular endothelial cells. PLoS One 8, e74343 (2013
25. Rajadas, J., et al. Enhanced Aβ (1-40) production in endothelial cells stimulated with fibrillar Aβ (1-42). PLoS One 8, e58194 (2013
26. Giménez-Llort, L., et al. Modeling behavioral and neuronal symptoms of Alzheimer's disease in mice: a role for intraneuronal amyloid. Neurosci. Biobehav. Rev. 31, 125-147 (2007
27. Garcia-Mesa, Y., et al. Physical exercise protects against Alzheimer's disease in 3xTg-AD mice. J. Alzheimer's Dis. 24, 421-454 (2011
28. Chirita, C., Necula, M., & Kuret, J. Ligand-dependent inhibition and reversal of tau filament formation. Biochemistry. 43, 2879-2887 (2004
29. Zhu, B., et al. Protein kinase A phosphorylation of tau-serine 214 reorganises microtubules and disrupts the endothelial cell barrier. Am J Physiol Lung Cell Mol Physiol. 299, 483-501 (2010
30. Molins, B., et al. C-reactive protein isoforms differ in their effects on thrombus growth. Arterioscler Thromb Vasc Biol. 28, 2239-2246 (2008
31. Ciabattoni, G., et al. Determinants of platelet activation in Alzheimer's disease. Neurobiol Aging. 28, 336-342 (2007
32. Desai, B. S., Schneider, J. A., Li, J. L., Carvey, P. M., & Hendey, B. Evidence of angiogenic vessels in Alzheimer's disease. J Neural Transm. 116, 587-597 (2009
33. Meyer, E. P., Ulmann-Schuler, A., Staufenbiel, M., & Krucker, T. Altered morphology and 3D architecture of brain vasculature in a mouse model for Alzheimer's disease. Proc Natl Acad Sci USA. 105, 3587-3592 (2008
34. Solito, R., et al. Mitochondrial aldehyde dehydrogenase-2 activation prevents β-Amyloid-induced endothelial cell dysfunction and restores angiogenesis. J. Cell Sci. 126, 1952-1961 (2013
35. Lassance, L., et al. Hyperinsulinemia stimulates angiogenesis of human fetoplacental endothelial cells: a possible role of insulin in placental hypervascularization in diabetes mellitus. J. Clin. Endocrinol. Metab. 98, 2013-1210 (2013
36. Miyagami, M., & Katayama, Y. Angiogenesis of glioma: evaluation of ultrastructural characteristics of microvessels and tubular bodies (Weibel-Palade) in endothelial cells and immunohistochemical findings with VEGF and p53 protein. Med Mol Morphol. 38, 36-42 (2005
37. Freude, S., Schilbach, K., & Schubert, M. The role of IGF-1 receptor and insulin receptor signaling for the pathogenesis of Alzheimer's disease: from model organisms to human disease. Curr Alzheimer Res. 6, 213-223 (2009
38. Andrieu-Soler, C., et al. Downregulation of IRS-1 expression causes inhibition of corneal angiogenesis. Invest Ophthalmol. Vis Sci 46, 4072-4078 (2005
39. Moser, C., et al. Inhibition of insulin-like growth factor-I receptor (IGF-IR) using NVP-AEW541, a small molecule kinase inhibitor, reduces orthotopic pancreatic cancer growth and angiogenesis. Eur J Cancer. 44, 1577-1586 (2008
40. Balczon, R., et al. Pseudomonas aeruginosa exotoxin Y-mediated tau hyperphosphorylation impairs microtubule assembly in pulmonary microvascular endothelial cells. PLoS One. 8, e74343 (2013
41. Kennedy, A., et al. Angiogenesis and blood vessel stability in inflammatory arthritis. Arthritis Rheum. 62, 711-21 (2010
42. Rajas, J., et al. Enhanced Aβ (1-40) production in endothelial cells stimulated with fibrillar Aβ (1-42). PLoS One. 8, e58194 (2013
43. Bi, B. T., et al. Promotion of β-Amyloid production by C-reactive protein and its implications in the early pathogenesis of Alzheimer's disease/. Neurochem. Int. 60, 257-266 (2012
44. García-Mesa, Y., et al. Physical exercise neuroprotects ovariectomized 3xTg-AD mice through BDNF mechanisms. Psychoneuroendocrinology. 45, 154-166 (2014
45. Wang, X., Chen, Q., & Xing, D. Focal adhesion kinase activates NF-? B via the ERK1/2 and p38MAPK Pathways in amyloid-β 25-35-induced apoptosis in PC12 cells. J. Alzheimers Dis. 32, 77-94 (2012
46. Ma, Q. L., et al. Beta-Amyloid oligomers induce phosphorylation of tau and inactivation of insulin receptor substrate via c-Jun N-Terminal kinase signaling: suppression by omega-3 fatty acids and curcumin. J. Neurosci. 29, 9078-9089 (2009
47. Bulic, B., Pickhardt, M., Mandelkow, E. M., & Mandelkow, E. Tau protein and tau aggregation inhibitors. Neuropharmacology. 59, 276-289 (2010
48. Adams, S. J., DeTure, M. A., McBride, M., Dickson, D. W., & Petrucelli, L. Three repeat isoforms of tau inhibit assembly of four repeat tau filaments. PLoS One. 5, e10810 (2010
49. Patterson, K. R., et al. Characterization of prefibrillar Tau oligomers in vitro and in Alzheimer disease. J. Biol. Chem. 286, 23063-23076. (2011
50. Thiele, J. R., et al. Dissociation of pentameric to monomeric C-reactive protein localizes and aggravates inflammation. Circulation. 130, 35-50 (2014
51. Torzewski, M., Bilal Waqar, A., & Fan, J. Animal models of C-reactive protein. Mediators of Inflammation. ID683598. (2014
52. Head, E. A canine model of human aging and Alzheimer's disease. Biochim Biophys Acta. 1832, 1384-1389 (2013
53. Mirra, S. S., et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology. 41, 479-486 (1991
54. Braak, H., Alafuzoff, I., Arzberger, T., Kretzschmar, H., & Del Tredici, K. Staging of Alzheimer's disease-Associated neurofibrillary pathologyusing paraffin sectionsand immunohistochemistry. Neuropathol. 112, 389-404 (1996
55. Hyman, B. T., et al. National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease. Alzheimers Dement. 8, 1-13. (2012